Perflenapent Completed Phase 1 Trials for Glioblastoma Multiforme (GBM) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02189109The Effects of NVX-108 as a Radiation Sensitizer in Glioblastoma